期刊文献+

浓缩自体骨髓移植治疗非创伤性股骨头坏死的临床研究 被引量:20

The clinical research on treatment for nontraumatic osteonecrosis of the femoral head with the implantation of concentrated autologous bone marrow
原文传递
导出
摘要 目的探讨富含单个核细胞的浓缩骨髓血移植治疗非创伤性股骨头坏死的临床疗效。方法应用自体骨髓血浓缩技术,在术中完成骨髓血采集、含有骨髓基质干细胞(BMSCs)的骨髓浓集,通过细针多孔减压手术回植入股骨头坏死区,治疗非创伤性股骨头坏死45例(59髋),男36例,女9例;年龄16~56岁,平均37·5岁,其中根据国际骨循环学会(ARCO)分期,Ⅰ期2髋,Ⅱ期48髋,ⅢA期9髋,激素性20例(29髋),酒精性18例(22髋),特发性7例(8髋)。对浓集集前后包含BMSCs的骨髓单个核细胞(BMMCs)计数,分析年龄、性别、病种对BMMCs的影响;平均随访27·64个月(12~40个月),结合Harris评分和影像学检查综合评定临床疗效。结果平均抽取骨髓血(126±15)m,l经浓集后BMMCs数量从(12·23±3·2)×106/ml增加到了(35·23±12)×106/ml。BMMCs细胞数量与年龄,病因和性别有一定相关性,酒精性患者要多于激素性患者,40岁以上患者细胞数量降低。临床总体成功率为79·66%(影像学有效率为76·27%),其中Ⅰ期100%,Ⅱ期87·5%,ⅢA期成功率44%,激素性坏死患者预后较差。Harris评分手术前后比较有统计学意义(P<0·05)。结论富含单个核细胞的浓缩骨髓血移植技术是一种快速、简便、安全的临床细胞治疗手段,与髓心减压技术一起可以有效缓解各期的股骨头坏死患者症状,并在一定程度上防止股骨头塌陷或进展。 Objective To study the implantation of the concentrated autologous bone marrow containing mononuelear cells in necrotic lesion of the femoral head and to determine the etfeet of the method. Methods The study included 4. 5 patients (59 hips, nine females, 36 males, mean age 37.50 years; ranging from 16 to 56 years) with stage Ⅰ -Ⅲ A nontraumatic avascular necrosis of the femoral head according to the system of the Association Research Circulation Osseous. Concentrated bone marrow (30 - 50 ml) containing mononuelear cells were obtained from the iliac crest of patient with the Cell Processor System. Concentrated bone marrow was injected through a core decompression channel into the femoral head. The outcome was determined by the Harris hip score, progression in radiographic stages, and the need for hip replacement. The mean follow-up time was 27.64 months (range 12 to 40 months). Results Pre-and postoperative evaluations showed that the mean Harris hip score increased from 71 to 83. Clinically the overall success rate was 79. 66%, and hip replacement was done in seven of 59 hips ( 11.86% ). Radiologieally, 14 of 59 hips exhibited femoral head collapse or narrowing of the coxofemoral joint space, and the overall failure rate was 23.73%. The number of bone marrow mononuelear cells ( BMMCs ) increased from (12.23 ± 3.2) × 10^6/ml pre-concentration to (35.23 ±12) × 10^6/ml post-concentration. Conclusions The implantation of concentrated autologous bone marrow containing mononuclear cells relieve.s hip pain, and prevents the progression of osteonecrosis. Therefore, it may be a treatment of choices particularly in stage Ⅰ - Ⅱ nontraumatic osteonecrosis of the femoral head.
出处 《中华关节外科杂志(电子版)》 CAS 2011年第4期11-15,共5页 Chinese Journal of Joint Surgery(Electronic Edition)
基金 卫生部属(管)医院临床学科重点项目(2010~2012)
关键词 股骨头坏死 骨髓 干细胞移植 Femur head necrosis Bone marrow Stem cell transplantation
  • 相关文献

参考文献15

  • 1Hernigou P,Beaujean F,Lambotte JC.Decrease in the mesenchymal stem cell pool in the proximal femur in corticosteroid-induced osteonecrosis.J Bone Joint Surg Br,1999,81(2):349-355.
  • 2Wang GJ,Cui Q,Balian G.The Nicolas Andry award.The pathogenesis and prevention of steroid-induced osteonecrosis.Clin Orthop,2000(370):295-310.
  • 3Suh KT,Kim SW,Roh HL,et al.Decreased osteogenic differentiation of mesenchymal stem cells in alcohol-induced osteonecrosis.Clin Orthop Relat Res,2005(431):220-225.
  • 4Bozic KJ,Zurakowski D,Thornhill TS.Survivorship analysis of hips treated with core decompression for nontraumatic osteonecrosis of the femoral head.J Bone Joint Surg Am,1999,81(2):200-209.
  • 5Lieberman JR.Core decompression for osteonecrosis of the hip.Clin Orthop Relat Res,2004(418):29-33.
  • 6Mont MA,Ragland PS,Etienne G.Core decompression of the femoral head for osteonecrosis using percutaneous multiple small-diameter drilling.Clin Orthop Relat Res,2004(429):131-138.
  • 7Hernigou P,Beaujean.Treatment of osteonecrosis with autologous bone marrow grafting.Clin Orthop Relat Res,2002(405):14-23.
  • 8Gangji V,Hauzeur JP.Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells.Surgical technique.J Bone Joint Surg Am,2005,87 suppl 1(Pt 1):106-112.
  • 9Wang BL,Sun W,Shi ZC,et al.Decreased proliferation of mesenchymal stem cell in corticosteroid-induced osteonecrosis of the femoral head.Orthopedics,2008,31(5):444.
  • 10Petrigliano FA,Lieberman JR.Osteonecrosis of the hip:novel approaches to evaluation and treatment.Clin Orthop Relat Res,2007(465):53-62.

二级参考文献15

  • 1Muschler GF,Midura RJ.Connective tissue progenitors:practical concepts for clinical applications.Clin Orthop Relat Res,2002,(395):66-80.
  • 2Connolly JF.Clinical use of marrow osteoprogenitor cells to stimulate osteogenesis.Clin Orthop Relat Res,1998,(355 Suppl):257-266.
  • 3Werntz JR,Lane JM,Burstein AH,et al.Qualitative and quantitative analysis of orthotopic bone regeneration by marrow.J Orthop Res,1996,14:85-93.
  • 4Majors AK,Boehm CA,Nitto H,et al.Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation.J Orthop Res,1997,15:546-557.
  • 5Hernigou P,Beaujean F.Treatment of osteonecrosis with autologous bone marrow grafting.Clin Orthop Relat Res,2002,(405):14-23.
  • 6Hernigou P,Poignard A,Manicom O,et al.The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone.J Bone Joint Surg (Br),2005,87:896-902.
  • 7Connolly JF,Guse R,Tiedeman J,et al.Autologous marrow injection as a substitute for operative grafting of tibial nonunions.Clin Orthop Relat Res,1991,(266):259-270.
  • 8Connolly J,Guse R,Lippiello L,et al.Development of an osteogenic bone-marrow preparation.J Bone Joint Surg (Am),1989,71:684-691.
  • 9Younger EM,Chapman MW.Morbidity at bone graft donor sites.J Orthop Trauma,1989,3:192-195.
  • 10Muscbler GF,Nakamoto C,Griffith LG.Engineering principles of clinical cell-based tissue engineering.J Bone Joint Surg (Am),2004,86:1541-1558.

共引文献30

同被引文献289

引证文献20

二级引证文献182

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部